Alstom ADR (OTCMKTS:ALSMY – Get Free Report) shares gapped down before the market opened on Tuesday after Kepler Capital Markets downgraded the stock from a buy rating to a hold rating. The stock had previously closed at $3.12, but opened at $3.02. Alstom shares last traded at $3.01, with a volume of 23,553 shares changing hands.
Several other equities research analysts have also recently weighed in on the stock. Barclays restated an “underweight” rating on shares of Alstom in a research report on Wednesday, December 3rd. Citigroup upgraded Alstom from a “neutral” rating to a “buy” rating in a report on Friday, December 5th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Alstom in a report on Friday, November 14th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy”.
View Our Latest Stock Analysis on Alstom
Alstom Stock Performance
About Alstom
Alstom is a global leader in the transportation sector, specializing in the design, manufacture and delivery of rail infrastructure, rolling stock and signaling systems. The company’s portfolio includes high-speed trains, regional and commuter trains, metros, trams and e-buses, as well as digital mobility solutions for railway networks. In addition to new equipment, Alstom offers a comprehensive suite of services ranging from maintenance and modernization to spare parts management and on-site support.
Founded in France with roots tracing back to the early 20th century, Alstom has evolved through a series of mergers and acquisitions to become one of the world’s largest rail transport equipment suppliers.
Recommended Stories
- Five stocks we like better than Alstom
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A month before the crash
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- YDES Could Be 2026’s Biotech Breakthrough
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Alstom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alstom and related companies with MarketBeat.com's FREE daily email newsletter.
